We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+52.12%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$2.58B
AUM Growth
+$1.06B
Cap. Flow
+$1.07B
Cap. Flow %
41.35%
Top 10 Hldgs %
67.03%
Holding
812
New
224
Increased
195
Reduced
131
Closed
143

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$211M
2
NVDA icon
NVIDIA
NVDA
+$146M
3
META icon
Meta Platforms (Facebook)
META
+$111M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$42.4M
5
AAPL icon
Apple
AAPL
+$35.7M

Sector Composition

Rank Sector Weight
1 Financials 29.84%
2 Technology 29.38%
3 Healthcare 23.72%
4 Communication Services 6.1%
5 Energy 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIST
226
DELISTED
Distoken Acquisition Corp
DIST
$261K 0.01%
+24,232
New +$258K
WESTW
227
DELISTED
Westrock Coffee Company Warrants
WESTW
$259K 0.01%
112,685
+3,011
+3% +$6.64K
ZFOXW
228
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
$255K 0.01%
2,836,706
+2,148,492
+312% +$110K
EXAS
229
DELISTED
Exact Sciences
EXAS
$248K 0.01%
+3,590
New +$227K
HERZ
230
Herzfeld Credit Income Fund
HERZ
$32.7M
$242K 0.01%
+9,868
New +$236K
ALUR.WS
231
DELISTED
Allurion Technologies Warrants
ALUR.WS
$230K 0.01%
911,171
-55,569
-6% -$16.8K
EXEL icon
232
CALL
Exelixis
EXEL
$12.7B
$226K 0.01%
+83,000
New +$1.84M
AFJKR
233
Aimei Health Technology Co Right
AFJKR
$226K 0.01%
+1,129,000
New +$223K
EVLVW
234
DELISTED
Evolv Technologies Warrant
EVLVW
$214K 0.01%
351,182
+255,250
+266% +$151K
JWSM.WS
235
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$211K 0.01%
979,191
+878,900
+876% +$95.5K
SKGRW
236
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$205K 0.01%
436,656
+336,656
+337% +$103K
CZOO
237
DELISTED
Cazoo Group Ltd
CZOO
$204K 0.01%
+17,000
New +$81.5K
CLBR.WS
238
DELISTED
Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
CLBR.WS
$202K 0.01%
+439,951
New +$191K
RNWWW
239
ReNew Energy Global PLC Warrant
RNWWW
$24.1K
$201K 0.01%
402,851
+302,851
+303% +$204K
ALC icon
240
Alcon
ALC
$36.8B
$201K 0.01%
+2,416
New +$194K
BUJAR
241
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Rights
BUJAR
$199K 0.01%
848,862
-2,717
-0.3% -$461
NETDW
242
DELISTED
Nabors Energy Transition Corp II Warrant
NETDW
$194K 0.01%
1,554,098
+134,410
+9% +$15.9K
NBST
243
DELISTED
Newbury Street Acquisition Corporation Common Stock
NBST
$192K 0.01%
+17,653
New +$190K
RGTIW icon
244
Rigetti Computing Warrants
RGTIW
$182M
$191K 0.01%
779,050
+80,757
+12% +$19.5K
KDKRW
245
Kodiak AI Warrants
KDKRW
$189K 0.01%
1,022,489
-23,393
-2% -$4.5K
SPY icon
246
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$187K 0.01%
+50,000
New +$24.9M
ENGNW icon
247
enGene Therapeutics Warrants
ENGNW
$5M
$182K 0.01%
34,998
-103,714
-75% -$316K
PGSS.WS
248
DELISTED
Pegasus Digital Mobility Acquisition Corp. Redeemable Warrants
PGSS.WS
$175K 0.01%
461,419
-161,544
-26% -$38.3K
HLLY.WS
249
DELISTED
Holley Inc Warrants
HLLY.WS
$175K 0.01%
499,600
+172,694
+53% +$67.1K
BRACR
250
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
$174K 0.01%
908,453
-65,281
-7% -$12.2K

Similar funds

Cowen and Company's Q1 2024 Portfolio in Review

As of Q1 2024, Cowen and Company held 812 positions worth $2.58B, up 69% from $1.52B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $1.07B of net new capital in Q1 2024, opening 224 new positions and adding to 195 existing holdings. Its largest new stake was Protagonist Therapeutics: 1,557,636 shares worth $45.1M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Screaming Eagle Acquisition Corp. Class A Ordinary Shares, an estimated $30.3M trimmed.

  • Cowen and Company's largest Q1 2024 buy was Protagonist Therapeutics: 1,557,636 shares worth $45.1M.
  • Cowen and Company added most to Coinbase in Q1 2024, an estimated $211M increase.
  • Cowen and Company's biggest Q1 2024 reduction was Screaming Eagle Acquisition Corp. Class A Ordinary Shares, cutting an estimated $30.3M.
  • Cowen and Company fully exited State Street Energy Select Sector SPDR ETF in Q1 2024, selling an estimated $33M.
  • Cowen and Company's ten largest holdings make up 67% of its $2.58B portfolio in Q1 2024.
  • Cowen and Company opened 224 new positions and closed 143 in Q1 2024.
  • Cowen and Company's portfolio value rose 69% quarter-over-quarter to $2.58B.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.